Correlation Between Novo Nordisk and Netcompany Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Netcompany Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Netcompany Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Netcompany Group AS, you can compare the effects of market volatilities on Novo Nordisk and Netcompany Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Netcompany Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Netcompany Group.

Diversification Opportunities for Novo Nordisk and Netcompany Group

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Novo and Netcompany is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Netcompany Group AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Netcompany Group and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Netcompany Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Netcompany Group has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Netcompany Group go up and down completely randomly.

Pair Corralation between Novo Nordisk and Netcompany Group

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Netcompany Group. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 1.01 times less risky than Netcompany Group. The stock trades about -0.12 of its potential returns per unit of risk. The Netcompany Group AS is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  30,780  in Netcompany Group AS on September 12, 2024 and sell it today you would earn a total of  6,260  from holding Netcompany Group AS or generate 20.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  Netcompany Group AS

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Netcompany Group 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Netcompany Group AS are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Netcompany Group displayed solid returns over the last few months and may actually be approaching a breakup point.

Novo Nordisk and Netcompany Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Netcompany Group

The main advantage of trading using opposite Novo Nordisk and Netcompany Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Netcompany Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Netcompany Group will offset losses from the drop in Netcompany Group's long position.
The idea behind Novo Nordisk AS and Netcompany Group AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets